{"id":699,"date":"2004-03-26T00:00:00","date_gmt":"2007-04-09T12:07:24","guid":{"rendered":""},"modified":"2022-09-25T21:26:43","modified_gmt":"2022-09-26T01:26:43","slug":"letter-to-the-standing-committee-on-industry-science-and-technology-re-bill-c-9-an-act-to-amend-the-patent-act-and-the-food-and-drugs-act","status":"publish","type":"publication22","link":"https:\/\/www.hivlegalnetwork.ca\/site\/letter-to-the-standing-committee-on-industry-science-and-technology-re-bill-c-9-an-act-to-amend-the-patent-act-and-the-food-and-drugs-act\/","title":{"rendered":"Letter to the Standing Committee on Industry, Science and Technology re: Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act"},"content":{"rendered":"&#8221;I write to follow up on our previous submissions to the Standing Committee regarding Bill C-9, Canada\u2019s laudable initiative to implement the WTO General Council Decision of August 30, 2003 to enable countries lacking sufficient pharmaceutical manufacturing capacity to &#8216;make effective use&#8217; of compulsory licensing to obtain lower cost generic pharmaceutical products manufactured in Canada\u2026&#8221;<br \/>\n<!-- Jean Chr\u00e9tien Pledge to Africa, Bill C-9, patent, Patent Act, Food and Drugs Act, compulsory licensing, export, developing countries, right of first refusal, generic, manufacturer, producer, pharmaceutical, product, access to medicines, World Trade Organization, Doha Declaration, Decision of 30 August 2003 \/ August 30, 2003 Decision, TRIPS, Agreement on Trade-Related Aspects of Intellectual Property Rights, Standing Committee on Industry, Science and Technology, House of Commons, Parliament, Right to health, Schedule 1 --><p class=\"download-link-button\"><a class=\"download-link en\" title=\"Letter to the Standing Committee on Industry, Science and Technology re: Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act\" href=\"https:\/\/www.hivlegalnetwork.ca\/site\/download\/9939\/?tmstv=1777602674\" rel=\"nofollow\">\r\n\tDownload<\/a><\/p>","protected":false},"author":1,"featured_media":0,"menu_order":0,"template":"","meta":{"_acf_changed":false,"footnotes":""},"publication_topics":[145],"publication_type":[170],"publication_language":[184,185],"class_list":["post-699","publication22","type-publication22","status-publish","hentry","publication_topics-access-to-medicines","publication_type-advocacy","publication_language-english","publication_language-french"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication22\/699","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication22"}],"about":[{"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/types\/publication22"}],"author":[{"embeddable":true,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":5,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication22\/699\/revisions"}],"predecessor-version":[{"id":20746,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication22\/699\/revisions\/20746"}],"wp:attachment":[{"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/media?parent=699"}],"wp:term":[{"taxonomy":"publication_topics","embeddable":true,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication_topics?post=699"},{"taxonomy":"publication_type","embeddable":true,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication_type?post=699"},{"taxonomy":"publication_language","embeddable":true,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication_language?post=699"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}